Author:
Tevell Staffan,Baig Sharmin,Hellmark Bengt,Martins Simoes Patricia,Wirth Thierry,Butin Marine,Nilsdotter-Augustinsson Åsa,Söderquist Bo,Stegger Marc
Abstract
AbstractStaphylococcus capitis is a coagulase-negative staphylococcus that has been described primarily as causing bloodstream infections in neonatal intensive care units (NICUs), but has also recently been described in prosthetic joint infections (PJIs). The multidrug-resistant S. capitis subsp. urealyticus clone NRCS-A, comprising three sublineages, is prevalent in NICUs across the world, but its impact on other patient groups such as those suffering from PJIs or among adults planned for arthroplasty is unknown. Genome sequencing and subsequent analysis were performed on a Swedish collection of PJI isolates (n = 21), nasal commensals from patients planned to undergo arthroplasty (n = 20), NICU blood isolates (n = 9), operating theatre air isolates (n = 4), and reference strains (n = 2), in conjunction with an international strain collection (n = 248). The NRCS-A Outbreak sublineage containing the composite type V SCCmec-SCCcad/ars/cop element was present in PJIs across three Swedish hospitals. However, it was not found among nasal carrier strains, where the less virulent S. capitis subsp. capitis was most prevalent. The presence of the NRCS-A Outbreak clone in adult patients with PJIs demonstrates that dissemination occurs beyond NICUs. As this clone has several properties which facilitate invasive infections in patients with medical implants or immunosuppression, such as biofilm forming ability and multidrug resistance including heterogeneous glycopeptide-intermediate susceptibility, further research is needed to understand the reservoirs and distribution of this hospital-associated pathogen.
Funder
Värmland County Council, Sweden
Örebro University, Sweden
Research committee of Östergötland County Council, Sweden
Foundation for Medical Research at Örebro University Hospital
Örebro University
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Kurtz, S. M., Lau, E., Watson, H., Schmier, J. K. & Parvizi, J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 27(8 Suppl), 61–5 e1 (2012).
2. Kasina, P., Enocson, A., Lindgren, V. & Lapidus, L. J. Patient claims in prosthetic hip infections: A comparison of nationwide incidence in Sweden and patient insurance data. Acta Orthop. 89(4), 394–398 (2018).
3. Lindgren, V., Gordon, M., Wretenberg, P., Kärrholm, J. & Garellick, G. Deep infection after total hip replacement: A method for national incidence surveillance. Infect. Control Hosp. Epidemiol. 35(12), 1491–1496 (2014).
4. Kapadia, B. H. et al. Periprosthetic joint infection. Lancet 387(10016), 386–394 (2016).
5. Peel, T. N., Cole, N. C., Dylla, B. L. & Patel, R. Matrix-assisted laser desorption ionization time of flight mass spectrometry and diagnostic testing for prosthetic joint infection in the clinical microbiology laboratory. Diagn. Microbiol. Infect. Dis. 81(3), 163–168 (2015).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献